Document Detail


Opposing changes in N-acetylglucosaminyltransferase-V and -III during the cell cycle and all-trans retinoic acid treatment of hepatocarcinoma cell line.
MedLine Citation:
PMID:  10699467     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The changes in N-acetylglucosaminyltransferase-V and -III (GnT-V, GnT-III) during the cell-cycle of synchronized 7721 human hepatocarcinoma cell line were investigated. Using an HPLC method to assay GnT and flow cytometry (FCM) for cell cycle analysis, it was found that GnT-V showed the highest activity, but GnT-III reached the lowest activity when G(2)/M cells were most abundant. In contrast, GnT-V declined to the minimum while GnT-III elevated to maximum when G(0)/G(1) cells were most predominant. The opposing changes were more obvious when the activities of GnT-V and GnT-III were expressed as relative activities (activity of GnT-V or GnT-III/the sum of activities of GnT-V plus GnT-IV plus GnT-III). These opposing changes of GnT-V and GnT-III during the cell cycle might result from the different regulatory mechanisms of GnT-V and GnT-III expression in the cell cycle. The alterations in the structures of cell surface N-glycans were compatible with the changes of the activities of GnTs. The results from immunocytochemistry and Northern blot showed that the protein and mRNA contents of GnT-V were not significantly changed during the cell cycle. The activity of a cell cycle regulating protein kinase, p34(cdc2) kinase, correlated to the activity of GnT-V. These findings suggested that the change of GnT-V activity in cell cycle was not the consequence of the alteration of gene transcription or enzyme protein synthesis, but might be caused by the post-translational regulation. The decrease in GnT-V and the corresponding increase in GnT-III activities were also found after the cells were treated with all-trans retinoic acid (ATRA), and the mechanism of this might be different from that in the cell cycle.
Authors:
H B Guo; A L Jiang; T Z Ju; H L Chen
Related Documents :
1575717 - Regulation of meiotic maturation in the mammalian oocyte: interplay between exogenous c...
16903207 - Regulation of s phase.
19074847 - A peptide inhibitor derived from p55pik phosphatidylinositol 3-kinase regulatory subuni...
2906147 - Roles for the phosphatidylinositol cycle in early development.
12718757 - Nmr studies of the relationship between the changes of membrane lipids and the cisplati...
18594937 - Immortalization of human melanocytes does not alter the de novo properties of nitric ox...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Biochimica et biophysica acta     Volume:  1495     ISSN:  0006-3002     ISO Abbreviation:  Biochim. Biophys. Acta     Publication Date:  2000 Feb 
Date Detail:
Created Date:  2000-08-09     Completed Date:  2000-08-09     Revised Date:  2012-06-08    
Medline Journal Info:
Nlm Unique ID:  0217513     Medline TA:  Biochim Biophys Acta     Country:  NETHERLANDS    
Other Details:
Languages:  eng     Pagination:  297-307     Citation Subset:  IM    
Affiliation:
Key Laboratory of Glycoconjugate Research, Ministry of Health, Department of Biochemistry, Shanghai Medical University, Shanghai, PR China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antineoplastic Agents / pharmacology
Carcinoma, Hepatocellular / pathology
Cell Cycle / physiology
Cyclin-Dependent Kinases*
Flow Cytometry
G0 Phase / physiology
G1 Phase / physiology
G2 Phase / physiology
Horseradish Peroxidase / metabolism
Humans
Immunohistochemistry
Lectins / metabolism
Mitosis / physiology
N-Acetylglucosaminyltransferases / analysis,  genetics,  metabolism*
Protein-Serine-Threonine Kinases / genetics,  metabolism
RNA, Messenger / metabolism
Tretinoin / pharmacology*
Tumor Cells, Cultured
Chemical
Reg. No./Substance:
0/Antineoplastic Agents; 0/Lectins; 0/RNA, Messenger; 302-79-4/Tretinoin; EC 1.11.1.-/Horseradish Peroxidase; EC 2.4.1.-/N-Acetylglucosaminyltransferases; EC 2.4.1.144/beta-1,4-mannosyl-glycoprotein beta-1,4-N-acetylglucosaminyltransferase; EC 2.4.1.155/alpha-1,6-mannosylglycoprotein beta 1,6-N-acetylglucosaminyltransferase; EC 2.7.11.1/Protein-Serine-Threonine Kinases; EC 2.7.11.22/Cyclin-Dependent Kinases; EC 2.7.11.22/cyclin-dependent kinase-activating kinase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Phospholipase D-dependent and -independent mechanisms are involved in milk protein secretion in rabb...
Next Document:  Nuclear beta-catenin displays GSK-3beta- and APC-independent proteasome sensitivity in melanoma cell...